- Home
- ANIX vs VTGN Comparison
ANIX vs VTGN Comparison
Compare ANIX & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- VTGN
- Stock Information
- Founded
- ANIX 1982
- VTGN 1998
- Country
- ANIX United States
- VTGN United States
- Employees
- ANIX 5
- VTGN N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- ANIX Health Care
- VTGN Health Care
- Exchange
- ANIX Nasdaq
- VTGN Nasdaq
- Market Cap
- ANIX 135.3M
- VTGN 122.1M
- IPO Year
- ANIX 1987
- VTGN N/A
- Fundamental
- Price
- ANIX $4.14
- VTGN $4.45
- Analyst Decision
- ANIX Strong Buy
- VTGN
- Analyst Count
- ANIX 3
- VTGN 0
- Target Price
- ANIX $9.00
- VTGN N/A
- AVG Volume (30 Days)
- ANIX 155.7K
- VTGN 512.1K
- Earning Date
- ANIX 09-10-2025
- VTGN 11-13-2025
- Dividend Yield
- ANIX N/A
- VTGN N/A
- EPS Growth
- ANIX N/A
- VTGN N/A
- EPS
- ANIX N/A
- VTGN N/A
- Revenue
- ANIX N/A
- VTGN $721,000.00
- Revenue This Year
- ANIX N/A
- VTGN $9.14
- Revenue Next Year
- ANIX N/A
- VTGN $467.87
- P/E Ratio
- ANIX N/A
- VTGN N/A
- Revenue Growth
- ANIX N/A
- VTGN N/A
- 52 Week Low
- ANIX $2.07
- VTGN $1.90
- 52 Week High
- ANIX $4.98
- VTGN $4.79
- Technical
- Relative Strength Index (RSI)
- ANIX 52.15
- VTGN 58.56
- Support Level
- ANIX $4.05
- VTGN $3.60
- Resistance Level
- ANIX $4.60
- VTGN $4.13
- Average True Range (ATR)
- ANIX 0.24
- VTGN 0.34
- MACD
- ANIX -0.02
- VTGN -0.02
- Stochastic Oscillator
- ANIX 48.05
- VTGN 57.14
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.